UBS Group AG - EFFECTOR THERAPEUTICS INC ownership

EFFECTOR THERAPEUTICS INC's ticker is and the CUSIP is 28202V116. A total of 20 filers reported holding EFFECTOR THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
UBS Group AG ownership history of EFFECTOR THERAPEUTICS INC
ValueSharesWeighting
Q2 2023$2,698
+169.8%
19,692
+572.3%
0.00%
Q2 2022$1,0000.0%2,929
-3.9%
0.00%
Q1 2022$1,0000.0%3,049
+283.5%
0.00%
Q4 2021$1,000
-50.0%
795
-35.3%
0.00%
Q3 2021$2,0001,2280.00%
Other shareholders
EFFECTOR THERAPEUTICS INC shareholders Q2 2022
NameSharesValueWeighting ↓
Integrity Capital Management (HK) Ltd 66,181$58,0000.18%
ARISTEIA CAPITAL, L.L.C. 1,731,946$1,541,0000.03%
HIGHBRIDGE CAPITAL MANAGEMENT LLC 419,478$369,0000.01%
MMCAP International Inc. SPC 145,941$128,0000.01%
WHITEBOX ADVISORS LLC 298,145$262,0000.01%
CVI Holdings, LLC 88,462$78,0000.01%
LITTLEJOHN & CO LLC 16,666$15,0000.00%
EQUITEC PROPRIETARY MARKETS, LLC 37,700$33,0000.00%
PURA VIDA INVESTMENTS, LLC 100,541$88,0000.00%
III Capital Management 25,900$23,0000.00%
View complete list of EFFECTOR THERAPEUTICS INC shareholders